These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22020387)

  • 1. Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing.
    Myllykangas S; Buenrostro JD; Natsoulis G; Bell JM; Ji HP
    Nat Biotechnol; 2011 Oct; 29(11):1024-7. PubMed ID: 22020387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the efficiency of genomic loci capture using oligonucleotide arrays for high throughput resequencing.
    Lee H; O'Connor BD; Merriman B; Funari VA; Homer N; Chen Z; Cohn DH; Nelson SF
    BMC Genomics; 2009 Dec; 10():646. PubMed ID: 20043857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deep resequencing of the human cancer genome using next-generation technologies.
    Myllykangas S; Ji HP
    Biotechnol Genet Eng Rev; 2010; 27():135-58. PubMed ID: 21415896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide in situ exon capture for selective resequencing.
    Hodges E; Xuan Z; Balija V; Kramer M; Molla MN; Smith SW; Middle CM; Rodesch MJ; Albert TJ; Hannon GJ; McCombie WR
    Nat Genet; 2007 Dec; 39(12):1522-7. PubMed ID: 17982454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism discovery in high-throughput resequenced microarray-enriched human genomic loci.
    Antipova AA; Sokolsky TD; Clouser CR; Dimalanta ET; Hendrickson CL; Kosnopo C; Lee CC; Ranade SS; Zhang L; Blanchard AP; McKernan KJ
    J Biomol Tech; 2009 Dec; 20(5):253-7. PubMed ID: 19949697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment of super-sized resequencing targets from the human genome.
    Olson M
    Nat Methods; 2007 Nov; 4(11):891-2. PubMed ID: 17971778
    [No Abstract]   [Full Text] [Related]  

  • 7. High-throughput resequencing of target-captured cDNA in cancer cells.
    Ueno T; Yamashita Y; Soda M; Fukumura K; Ando M; Yamato A; Kawazu M; Choi YL; Mano H
    Cancer Sci; 2012 Jan; 103(1):131-5. PubMed ID: 21929543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing.
    Bauer MA; Chavan SS; Peterson EA; Heuck CJ; Johann DJ
    BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S3. PubMed ID: 25350881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
    Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex amplification of large sets of human exons.
    Porreca GJ; Zhang K; Li JB; Xie B; Austin D; Vassallo SL; LeProust EM; Peck BJ; Emig CJ; Dahl F; Gao Y; Church GM; Shendure J
    Nat Methods; 2007 Nov; 4(11):931-6. PubMed ID: 17934468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does massively parallel DNA resequencing signify the end of histopathology as we know it?
    Aparicio SA; Huntsman DG
    J Pathol; 2010 Jan; 220(2):307-15. PubMed ID: 19921711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer.
    Kubo T; Kuroda Y; Kokubu A; Hosoda F; Arai Y; Hiraoka N; Hirohashi S; Shibata T
    Pancreas; 2009 Oct; 38(7):e200-6. PubMed ID: 19893451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Illumina Genome Analyzer and Roche 454 GS FLX for resequencing of hypertrophic cardiomyopathy-associated genes.
    Dames S; Durtschi J; Geiersbach K; Stephens J; Voelkerding KV
    J Biomol Tech; 2010 Jul; 21(2):73-80. PubMed ID: 20592870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of oligonucleotide sequence capture arrays and comparison of next-generation sequencing platforms for use in molecular diagnostics.
    Hoppman-Chaney N; Peterson LM; Klee EW; Middha S; Courteau LK; Ferber MJ
    Clin Chem; 2010 Aug; 56(8):1297-306. PubMed ID: 20562348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of massively parallel nucleotide sequencing with oligonucleotide microarrays for global transcription profiling.
    Bradford JR; Hey Y; Yates T; Li Y; Pepper SD; Miller CJ
    BMC Genomics; 2010 May; 11():282. PubMed ID: 20444259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.
    Summerer D; Schracke N; Wu H; Cheng Y; Bau S; Stähler CF; Stähler PF; Beier M
    Genomics; 2010 Apr; 95(4):241-6. PubMed ID: 20138981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
    J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
    Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
    Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening the human exome: a comparison of whole genome and whole transcriptome sequencing.
    Cirulli ET; Singh A; Shianna KV; Ge D; Smith JP; Maia JM; Heinzen EL; Goedert JJ; Goldstein DB;
    Genome Biol; 2010; 11(5):R57. PubMed ID: 20598109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.
    Bourgon R; Lu S; Yan Y; Lackner MR; Wang W; Weigman V; Wang D; Guan Y; Ryner L; Koeppen H; Patel R; Hampton GM; Amler LC; Wang Y
    Clin Cancer Res; 2014 Apr; 20(8):2080-91. PubMed ID: 24573554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.